Bryxta 300mg Injection

Colorectal cancer

• Headache
• Vision changes
• Confusion
• Severe allergic reactions
• High Blood pressure
• Numbness in hands or feet
• Weakness and lack of energy
• Diarrhea, nausea, vomiting, abdominal pain
• Constipation
• Loss of appetite

Bryxta 300mg tablet should taken under the strict supervision of a healthcare professional. Taking in the wrong way may cause severe side effects. Follow the prescribed dosage as recommended and schedule exactly as advised by the doctor. Do not chew or crush the medication as it may reduce its effectiveness and interfere with how the medication is absorbed in the body.

Colorectal cancer is caused by genetic mutations in colon cells, causing them to grow uncontrollably and become cancerous. Bryxta 300 mg tablet contains Bevacizumab, a VEGF inhibitor that blocks vascular endothelial growth factor (VEGF), which tumors use to form new blood vessels. The medication helps slow tumor growth, reduce the risk of metastasis, and complement other cancer treatments.

• McCormack, P. L., & Keam, S. J. (2008). Bevacizumab: a review of its use in metastatic colorectal cancer. Drugs, 68(4), 487-506.
• Burger, R. A., Brady, M. F., Bookman, M. A., Fleming, G. F., Monk, B. J., Huang, H., ... & Liang, S. X. (2011). Incorporation of bevaciz
• Bakri, S. J., Snyder, M. R., Reid, J. M., Pulido, J. S., & Singh, R. J. (2007). Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology, 114(5), 855-859.
• Keating, G. M. (2014). Bevacizumab: a review of its use in advanced cancer. Drugs, 74(16), 1891-1925.
• Ferrara, N., Hillan, K. J., Gerber, H. P., & Novotny, W. (2004). Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nature reviews Drug discovery, 3(5), 391-400.